From: Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level
TPF(n = 707)
PF(n = 137)
TP(n = 147)
P value
Complete response
14(2.0%)
3(2.2%)
3(2.0%)
0.013
Partial response
548(77.5%)
89(65.0%)
102(69.4%)
Stable disease
142(20.1%)
45(32.8%)
40(27.2%)
Progressive disease
3(0.4%)
0 (0.0%)
2(1.4%)